Varubi 70720-0101-02
Generic: Rolapitant
- Manufacturer
- Tersera Therapeutics Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 7, 2015
- Listing Expires
- December 31, 2026
- Application
- NDA206500
Need to source Varubi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rolapitant Hydrochloride | 90 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Neurokinin 1 Antagonists [MoA]
Selected Package
70720-0101-02Selected2 TABLET in 1 BLISTER PACK (70720-101-02)